123 related articles for article (PubMed ID: 8616839)
1. Identification of two candidate tumor suppressor genes on chromosome 17p13.3.
Schultz DC; Vanderveer L; Berman DB; Hamilton TC; Wong AJ; Godwin AK
Cancer Res; 1996 May; 56(9):1997-2002. PubMed ID: 8616839
[TBL] [Abstract][Full Text] [Related]
2. Identification of a zinc-finger gene at 6q25: a chromosomal region implicated in development of many solid tumors.
Abdollahi A; Roberts D; Godwin AK; Schultz DC; Sonoda G; Testa JR; Hamilton TC
Oncogene; 1997 Apr; 14(16):1973-9. PubMed ID: 9150364
[TBL] [Abstract][Full Text] [Related]
3. Allelic deletion on chromosome 17p13.3 in early ovarian cancer.
Phillips NJ; Ziegler MR; Radford DM; Fair KL; Steinbrueck T; Xynos FP; Donis-Keller H
Cancer Res; 1996 Feb; 56(3):606-11. PubMed ID: 8564979
[TBL] [Abstract][Full Text] [Related]
4. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium.
Lerman MI; Minna JD
Cancer Res; 2000 Nov; 60(21):6116-33. PubMed ID: 11085536
[TBL] [Abstract][Full Text] [Related]
5. Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer.
Fullwood P; Marchini S; Rader JS; Martinez A; Macartney D; Broggini M; Morelli C; Barbanti-Brodano G; Maher ER; Latif F
Cancer Res; 1999 Sep; 59(18):4662-7. PubMed ID: 10493522
[TBL] [Abstract][Full Text] [Related]
6. Analysis of allelic imbalance on chromosome 17p13 in stage I and stage II epithelial ovarian cancers.
Wiper DW; Zanotti KM; Kennedy AW; Belinson JL; Casey G
Gynecol Oncol; 1998 Oct; 71(1):77-82. PubMed ID: 9784323
[TBL] [Abstract][Full Text] [Related]
7. Expression of OVCA1, a candidate tumor suppressor, is reduced in tumors and inhibits growth of ovarian cancer cells.
Bruening W; Prowse AH; Schultz DC; Holgado-Madruga M; Wong A; Godwin AK
Cancer Res; 1999 Oct; 59(19):4973-83. PubMed ID: 10519411
[TBL] [Abstract][Full Text] [Related]
8. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.
Cornelis RS; van Vliet M; Vos CB; Cleton-Jansen AM; van de Vijver MJ; Peterse JL; Khan PM; Børresen AL; Cornelisse CJ; Devilee P
Cancer Res; 1994 Aug; 54(15):4200-6. PubMed ID: 8033152
[TBL] [Abstract][Full Text] [Related]
9. [Chromosome arm 17p13.3: could HIC1 be the one ?].
Chopin V; Leprince D
Med Sci (Paris); 2006 Jan; 22(1):54-61. PubMed ID: 16386221
[TBL] [Abstract][Full Text] [Related]
10. Characterization of chromosome 9 in human ovarian neoplasia identifies frequent genetic imbalance on 9q and rare alterations involving 9p, including CDKN2.
Schultz DC; Vanderveer L; Buetow KH; Boente MP; Ozols RF; Hamilton TC; Godwin AK
Cancer Res; 1995 May; 55(10):2150-7. PubMed ID: 7743516
[TBL] [Abstract][Full Text] [Related]
11. A 400 kb novel deletion unit centromeric to the BRCA1 gene in sporadic epithelial ovarian cancer.
Tangir J; Muto MG; Berkowitz RS; Welch WR; Bell DA; Mok SC
Oncogene; 1996 Feb; 12(4):735-40. PubMed ID: 8632895
[TBL] [Abstract][Full Text] [Related]
12. Identification of candidate liver tumor suppressor genes from human 11p11.2 by transcription mapping of microcell hybrid cell lines.
Jahn JE; Ricketts SL; Coleman WB
Int J Oncol; 2003 Jun; 22(6):1303-10. PubMed ID: 12738998
[TBL] [Abstract][Full Text] [Related]
13. A deletion unit on chromosome 17q in epithelial ovarian tumors distal to the familial breast/ovarian cancer locus.
Jacobs IJ; Smith SA; Wiseman RW; Futreal PA; Harrington T; Osborne RJ; Leech V; Molyneux A; Berchuck A; Ponder BA
Cancer Res; 1993 Mar; 53(6):1218-21. PubMed ID: 8095178
[TBL] [Abstract][Full Text] [Related]
14. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
Simoneau AR; Spruck CH; Gonzalez-Zulueta M; Gonzalgo ML; Chan MF; Tsai YC; Dean M; Steven K; Horn T; Jones PA
Cancer Res; 1996 Nov; 56(21):5039-43. PubMed ID: 8895761
[TBL] [Abstract][Full Text] [Related]
15. DOC-2, a candidate tumor suppressor gene in human epithelial ovarian cancer.
Mok SC; Chan WY; Wong KK; Cheung KK; Lau CC; Ng SW; Baldini A; Colitti CV; Rock CO; Berkowitz RS
Oncogene; 1998 May; 16(18):2381-7. PubMed ID: 9620555
[TBL] [Abstract][Full Text] [Related]
16. Association of rat p15INK4B/p16INK4 deletions with monosomy 5 in kidney epithelial cell lines but not primary renal tumors.
Knapek DF; Serrano M; Beach D; Trono D; Walker CL
Cancer Res; 1995 Apr; 55(8):1607-12. PubMed ID: 7712460
[TBL] [Abstract][Full Text] [Related]
17. RPS6KA2, a putative tumour suppressor gene at 6q27 in sporadic epithelial ovarian cancer.
Bignone PA; Lee KY; Liu Y; Emilion G; Finch J; Soosay AE; Charnock FM; Beck S; Dunham I; Mungall AJ; Ganesan TS
Oncogene; 2007 Feb; 26(5):683-700. PubMed ID: 16878154
[TBL] [Abstract][Full Text] [Related]
18. Isolation of expressed sequences that include a gene for familial breast cancer (BRCA2) and other novel transcripts from a five megabase region on chromosome 13q12.
Jacob AN; Kandpal G; Kandpal RP
Oncogene; 1996 Jul; 13(1):213-21. PubMed ID: 8700550
[TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity and transcriptome analyses of a 1.2 Mb candidate ovarian cancer tumor suppressor locus region at 17q25.1-q25.2.
Presneau N; Dewar K; Forgetta V; Provencher D; Mes-Masson AM; Tonin PN
Mol Carcinog; 2005 Jul; 43(3):141-54. PubMed ID: 15937959
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the candidate 8p21 tumour suppressor, BNIP3L, in breast and ovarian cancer.
Lai J; Flanagan J; Phillips WA; Chenevix-Trench G; Arnold J
Br J Cancer; 2003 Jan; 88(2):270-6. PubMed ID: 12610513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
